We've found
184,457
clinical trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
PRECISION GRX Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)- Positive Subjects From the LATTE Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Raynaud Phenomenon Clinical Trial
The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Suicidal and Self-injurious Behavior Clinical Trial
An ED-based RCT of Lethal Means Counseling for Parents of At-Risk Youth
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Disease Clinical Trial
Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Safety Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Niemann-Pick Type C Disease Clinical Trial
An Open-label Treatment Protocol for VTS-270 in Patients With Neurologic Manifestations of NPC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hallux Abductovalgus Clinical Trial
Dysport in Hallux Abducto Valgus (HAV) Phase IIa
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Elevated Blood Pressure Clinical Trial
Mindfulness and Neural Cardiovascular Control in Humans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
An Open-Label Study to Assess Safety
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hearing Loss Clinical Trial
Community-Based Kiosks for Hearing Screening and Education
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
ADHD Clinical Trial
Evaluation of SPN-812 ER Low Dose in Adolescents With ADHD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Liver Cirrhosis, Biliary Clinical Trial
Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Iron Deficiency Anemia Clinical Trial
A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Dup15q Syndrome, CDKL5 Deficiency Disorder Clinical Trial
A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety of TD-1473 in Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma Clinical Trial
A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma Clinical Trial
A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Uremic Pruritus Clinical Trial
CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Recurrent Vulvovaginal Candidiasis Clinical Trial
A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Recurrent Vulvovaginal Candidiasis Clinical Trial
A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Recurrent Vulvovaginal Candidiasis Clinical Trial
A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Syphilis Clinical Trial
Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Infertility Clinical Trial
The Human Microbiome and IVF Outcomes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HPV - Anogenital Human Papilloma Virus Infection Clinical Trial
Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma Clinical Trial
A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Respiratory Syncytial Virus Clinical Trial
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Updated: 12/31/1969
PRECISION GRX Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)- Positive Subjects From the LATTE Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Raynaud Phenomenon Clinical Trial
Updated: 12/31/1969
The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Suicidal and Self-injurious Behavior Clinical Trial
Updated: 12/31/1969
An ED-based RCT of Lethal Means Counseling for Parents of At-Risk Youth
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 12/31/1969
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 12/31/1969
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Disease Clinical Trial
Updated: 12/31/1969
Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Safety Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Niemann-Pick Type C Disease Clinical Trial
Updated: 12/31/1969
An Open-label Treatment Protocol for VTS-270 in Patients With Neurologic Manifestations of NPC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hallux Abductovalgus Clinical Trial
Updated: 12/31/1969
Dysport in Hallux Abducto Valgus (HAV) Phase IIa
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Elevated Blood Pressure Clinical Trial
Updated: 12/31/1969
Mindfulness and Neural Cardiovascular Control in Humans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
An Open-Label Study to Assess Safety
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hearing Loss Clinical Trial
Updated: 12/31/1969
Community-Based Kiosks for Hearing Screening and Education
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
ADHD Clinical Trial
Updated: 12/31/1969
Evaluation of SPN-812 ER Low Dose in Adolescents With ADHD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Updated: 12/31/1969
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Updated: 12/31/1969
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Updated: 12/31/1969
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Updated: 12/31/1969
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Updated: 12/31/1969
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer (Diagnosis) Clinical Trial
Updated: 12/31/1969
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Liver Cirrhosis, Biliary Clinical Trial
Updated: 12/31/1969
Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Personalized CRT - MPP Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Personalized CRT - MPP Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Personalized CRT - MPP Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Iron Deficiency Anemia Clinical Trial
Updated: 12/31/1969
A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Dup15q Syndrome, CDKL5 Deficiency Disorder Clinical Trial
Updated: 12/31/1969
A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of TD-1473 in Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Melanoma Clinical Trial
Updated: 12/31/1969
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Melanoma Clinical Trial
Updated: 12/31/1969
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Updated: 12/31/1969
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Updated: 12/31/1969
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Updated: 12/31/1969
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Updated: 12/31/1969
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Uremic Pruritus Clinical Trial
Updated: 12/31/1969
CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Recurrent Vulvovaginal Candidiasis Clinical Trial
Updated: 12/31/1969
A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Recurrent Vulvovaginal Candidiasis Clinical Trial
Updated: 12/31/1969
A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Recurrent Vulvovaginal Candidiasis Clinical Trial
Updated: 12/31/1969
A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Syphilis Clinical Trial
Updated: 12/31/1969
Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Infertility Clinical Trial
Updated: 12/31/1969
The Human Microbiome and IVF Outcomes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HPV - Anogenital Human Papilloma Virus Infection Clinical Trial
Updated: 12/31/1969
Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma Clinical Trial
Updated: 12/31/1969
A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Respiratory Syncytial Virus Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Updated: 12/31/1969
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials